Dr Clay Comstock
American Association for Cancer Research (AACR)
Other, Medicine And Medical Sciences
My co-authors include
Targeting cell cycle and hormone receptor pathways in cancer
Cyclin D1 Is a Selective Modifier of Androgen-dependent Signaling and Androgen Receptor...
Journal of Biological Chemistry
The retinoblastoma tumor suppressor controls androgen signaling and human prostate canc...
Journal of Clinical Investigation
Identification of ASF/SF2 as a Critical, Allele-Specific Effector of the Cyclin D1b Onc...
Alternative Splicing of the Cyclin D1 Proto-Oncogene Is Regulated by the RNA-Binding Pr...
Functional Specificities of Brm and Brg-1 Swi/Snf ATPases in the Feedback Regulation of...
Molecular and Cellular Biology
Cyclin D1 Splice Variants: Polymorphism, Risk, and Isoform-Specific Regulation in Prost...
Clinical Cancer Research
Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associa...
Targeting the BAF57 SWI/SNF Subunit in Prostate Cancer: A Novel Platform to Control And...
Cyclin D3 action in androgen receptor regulation and prostate cancer
Unique Bisphenol A Transcriptome in Prostate Cancer: Novel Effects on ERβ Expression Th...
Environmental Health Perspectives
Retinoblastoma Tumor Suppressor Status Is a Critical Determinant of Therapeutic Respons...
The Complex Role of AR Signaling After Cytotoxic Insult: Implications for Cell Cycle Ba...
Impact of differential cyclin D1 expression and localisation in prostate cancer
British Journal of Cancer
Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer
Molecular Cancer Therapeutics
LS14: A Novel Human Adipocyte Cell Line that Produces Prolactin
Cyclic Nucleotide Specificity and Cross-Activation of Cyclic Nucleotide Receptors
Gene Profiling Analysis of Androgen Receptor Mediated Function
Androgen-mediated Control of the Cyclin D1-RB Axis: Implications for Prostate Cancer